Literature DB >> 15966867

Fetal and perinatal programming of appetite.

Roselle L Cripps1, Malgorzata S Martin-Gronert, Susan E Ozanne.   

Abstract

There is increasing concern about the rapidly rising incidence of obesity worldwide and its impact both on mortality, morbidity and the cost of healthcare. In the last 15 years, a large volume of research has linked low birth weight to many adult diseases in humans, such as Type II diabetes, cardiovascular disease, hypertension and the metabolic syndrome. Obesity is a causal factor in all these conditions. There are epidemiological studies linking low birth weight to increased adiposity, but the timing of the insult during gestation seems crucial, as reducing maternal nutrition in late gestation and during lactation causes a reduction in later obesity. Recent studies in animal models have provided clues towards mechanisms of altered appetite regulation following alterations in fetal and neonatal growth. The outcome of these and future studies could prove clinically crucial, particularly in the debate over the benefits of breast feeding, which provides a lower plane of nutrition compared with formula feeding.

Entities:  

Mesh:

Year:  2005        PMID: 15966867     DOI: 10.1042/CS20040367

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  23 in total

1.  Intergenerational transmission of the effects of acculturation on health in Hispanic Americans: a fetal programming perspective.

Authors:  Molly Fox; Sonja Entringer; Claudia Buss; Jessica DeHaene; Pathik D Wadhwa
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

2.  Metabolomic approach in milk from calorie-restricted rats during lactation: a potential link to the programming of a healthy phenotype in offspring.

Authors:  Mariona Palou; Juana María Torrens; Pedro Castillo; Juana Sánchez; Andreu Palou; Catalina Picó
Journal:  Eur J Nutr       Date:  2019-05-08       Impact factor: 5.614

Review 3.  Development of eating behavior: biology and context.

Authors:  Sheila Gahagan
Journal:  J Dev Behav Pediatr       Date:  2012-04       Impact factor: 2.225

4.  Elevated fetal adipsin/acylation-stimulating protein (ASP) in obese pregnancy: novel placental secretion via Hofbauer cells.

Authors:  K Sivakumar; M F Bari; A Adaikalakoteswari; S Guller; M O Weickert; H S Randeva; D K Grammatopoulos; C C Bastie; M Vatish
Journal:  J Clin Endocrinol Metab       Date:  2013-08-16       Impact factor: 5.958

Review 5.  Intergenerational transmission of the effects of maternal exposure to childhood maltreatment on offspring obesity risk: A fetal programming perspective.

Authors:  Karen L Lindsay; Sonja Entringer; Claudia Buss; Pathik D Wadhwa
Journal:  Psychoneuroendocrinology       Date:  2020-03-23       Impact factor: 4.905

Review 6.  Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing.

Authors:  D Andrew Crain; Sarah J Janssen; Thea M Edwards; Jerrold Heindel; Shuk-mei Ho; Patricia Hunt; Taisen Iguchi; Anders Juul; John A McLachlan; Jackie Schwartz; Niels Skakkebaek; Ana M Soto; Shanna Swan; Cheryl Walker; Teresa K Woodruff; Tracey J Woodruff; Linda C Giudice; Louis J Guillette
Journal:  Fertil Steril       Date:  2008-10       Impact factor: 7.329

Review 7.  Developmental origins of obesity: programming of food intake or physical activity?

Authors:  David S Gardner; Phillip Rhodes
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

Review 8.  Unraveling the obesity of OLETF rats.

Authors:  Timothy H Moran
Journal:  Physiol Behav       Date:  2007-11-29

Review 9.  The role of leptin in the regulation of neuroendocrine function and CNS development.

Authors:  Gwendolyn W Louis; Martin G Myers
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

10.  Maternal size in pregnancy and body composition in children.

Authors:  Catharine R Gale; M Kassim Javaid; Sian M Robinson; Catherine M Law; Keith M Godfrey; Cyrus Cooper
Journal:  J Clin Endocrinol Metab       Date:  2007-08-07       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.